Timothy G. Buchman, PhD, MD, FACS, FCCP, MCCM is currently the founding director of the Emory’s Critical Care Center (ECCC), which integrates ICUs throughout the Emory Healthcare system. The Center has assembled clinicians, teachers and investigators from diverse disciplines to deliver the Right Care, Right Now, Every Time. He is a member of the External Faculty of the Santa Fe Institute. He is an advisor to the James S. McDonnell Foundation. Before joining Emory, he served as the Edison Professor of Surgery and Director of Acute and Critical Care Surgery at Washington University in St. Louis. Prior to his 15 years on the faculty at Washington University, Dr. Buchman directed the surgical intensive care unit and founded the trauma service at Johns Hopkins Hospital in Baltimore, where he completed his surgical training.
His research has spanned the bench-to-bedside continuum, including NIH-funded studies of physiological dynamics; of patient monitoring; of the genetics of sepsis and of ICU end-of-life care. In the 1990's, Dr. Buchman noticed that patients dying of sepsis seemed to have very monotonous vital signs. Recognizing that the various vital organs interacted with one another, postdoc Paul Godin and Dr. Buchman suggested--and demonstrated--that the onset of sepsis was associated with uncoupling (and failure to recouple) of the various vital organs. This uncoupling in various critical illness has been redemonstrated and forms the basis for novel monitoring and detection strategies.
Dr. Buchman is past president of the Shock Society, the Society for Complex Acute Illness and the Society of Critical Care Medicine, the latter being the largest organization of critical care professionals worldwide.
Dr. Buchman’s current clinical activity focuses on promoting situation awareness in critical care to achieve better health, better care and lower costs. He was the principal investigator on a Round 1 CMMI Healthcare Innovation Award entitled “Rapid Training and Deployment of Non-Physician Providers in Critical Care”. The award includes two innovations—telemedicine and the use of advanced practice providers—to efficiently deliver high-reliability care to locations where critical care physicians are in short supply. The project achieved its objectives of delivering better, smarter care to the federal beneficiaries it serves, see link4. In the most current iteration, Dr. Buchman is focusing on “turning night into day” using transoceanic implementations of the care model. See, for example, link1 and link2. His current research activity focuses on precision medicine in the acute care space. See, for example, link3.
Dr. Buchman is a certificated Airline Transport Pilot and a Cirrus Standardized Instructor Pilot .
Dr. Gershengorn is an Associate Professor of Pulmonary and Critical Care Medicine at the University of Miami, Miller School of Medicine. She received her medical degree from Harvard Medical School and completed a residency in Internal Medicine at New York Presbyterian Hospital-Cornell and a fellowship in Pulmonary and Critical Care Medicine at New York Presbyterian Hospital-Columbia. Dr. Gershengorn’s research program focuses on the allocation of ICU resources and the impact such allocation has on the outcomes of critically ill patients. In particular, she is interested in understanding how (1) ICU staffing and (2) practices which may be tied to staffing affect patient morbidity and mortality.
Trained in Medicine and Anaesthesia in London and in Intensive Care in Hong Kong. Research interests in mechanical ventilation, antibiotic pharmacokinetics and optimal use of Intensive Care resources. Approximately 130 peer-reviewed publications. Main current interest is critical care education. Only (minor) claim to fame: persuading a group of friends (ex-friends?) to write the BASIC Collaboration courses, which have been taught in over 70 countries.
Professor Gordon is the Chair of Anaesthesia and Critical Care Medicine at Imperial College London. He trained in anaesthesia and intensive care medicine in the North West Thames region and obtained his MD at St Bartholomew’s. He has also worked at the Royal North Shore Hospital in Sydney, Australia and St Paul’s Hospital, Vancouver, Canada.
Prof Gordon has been an NIHR Clinician Scientist and is a Director of Research for the Intensive Care Foundation. He has been the Chief Investigator for two UK multi-centre septic shock trials (VANISH and LeoPARDS) and is part of the UK Critical Care Genomics group. He is now an NIHR Research Professor, investigating personalised medicine in sepsis.
Dr. Michael Pinsky is a Professor of Critical Care Medicine (primary), Bioengineering, Cardiovascular Diseases, Clinical & Translational Science, and Anesthesiology at the University of Pittsburgh, and Director for Clinical trials and Innovation at the University of Pittsburgh’s Center for Military Medicine research. He is also Docteur Honoris Casusa at the Universite Rene Descartes Paris V, School of Medicine in Paris, France. Dr. Pinsky is currently an Emeritus (Honorary) Attending at UPMC as well as a faculty member of the Center for Critical Care Nephrology at Pitt.
Dr. Pinsky received his MD from McGill University in Montreal, Quebec, Canada. Dr. Pinsky completed his post-graduate internal medicine residency training and pulmonary fellowship training at Stanford University, Stanford, California; senior medical residency at Orlando Regional Medical Center, Orlando, Florida; and advanced physiological training at Johns Hopkins Medical Institutes, Baltimore, Maryland.
Currently, Dr. Pinsky serves as the Principal Investigator of an R01 on “Using biological time series analysis to identify cardiorespiratory insufficiency,” and Co-Principal Investigator of an R01 on “Predicting patient instability noninvasively for nursing care (PPINNC).” He is also a Co-I on two other R-01s on subarachnoid hemorrhage and endothelial dysfunction during traumatic hemorrhage. He has been the Director of the Cardiopulmonary Research Laboratory for the past 38 years. Dr. Pinsky is the program director for an NIH National Research Service Award entitled "Experimental Therapeutics in Critical Illness" which he has directed for the last 19 years. He is also a part of the training faculty of the NIH grant, “Cardiovascular Bioengineering,” the Fogarty Foundation International Training Grant, “Enhancing research and informatics capacity for health information in Colombia (ENRICH),” and the NIH grant, “Anesthesia research training grant.” His primary research focus is on applied cardiopulmonary physiology in the diagnosis and management of cardiorespiratory insufficiency using machine learning and advanced analytic techniques in both humans and clinically-relevant animal models.
Dr. Pinsky is the Editor-in-Chief of eMedicine’s Critical Care Medicine section. Dr. Pinsky is on the editorial boards of the Critical Care, Journal of Critical Care, Current Opinion in Critical Care, the International Journal of Critical Care, the Annals of Critical Care, and Intensive Care Medicine, Board of Reviewers. He also provides journal referring for numerous publications.
Dr. Pinsky has published >300 peer reviewed manuscript, >250 chapters and 26 textbooks. View a list of Dr. Pinsky’s publications here.
David Pilcher trained in respiratory and general medicine in the UK before moving to Australia in 2002. He has worked as a specialist in Intensive Care Medicine at The Alfred Hospital in Melbourne since 2006. His interests include organ donation, lung transplantation, ECMO, mortality prediction modelling, and the epidemiology of Intensive Care medicine. He is the immediate past Chair of the ANZICS Centre for Outcome and Resource Evaluation (CORE), Director of the ANZICS Adult Patient Database and a medical advisor to DonateLife in Victoria. He is also a Monash University Practitioner Fellow and Adjunct Clinical Professor with the Department of Epidemiology and Preventive Medicine at Monash University.
Francesca Rubulotta, was
born in Catania, Italy. She obtained her MD with laude and commendation in July
1998 at the University of Catania, Italy. In 2002, Dr Rubulotta gained
accreditation in Anesthesia at the University of Trieste in Italy and later in 2004
she obtained her specialty in Intensive Care Medicine (ICM) at the Catholic University of Leuven in Belgium. Her
training in ICM took place in the USA, the Netherlands, and in Belgium.
She is currently working in the UK as
Consultant and Honorary Senior Clinical Lecturer in ICM and Anaesthesia at Imperial College, Charing Cross
and St Mary’s Hospital, NHS trust in London, UK. In 2012, she obtained her PhD
at the University of Catania, Italy. She is an executive Master in Business
administration at Imperial College London. Dr Rubulotta was the Chair of the Division of Professional Development (DPD) of the
European Society of Intensive Care Medicine (ESICM) and currently the Chair of
the CoBaTrICE project. Dr Rubulotta is a member
of the European Board of Intensive Care Medicine (EBICM) and a member of the
European Accreditation Board for Continue Medical Education (EACCME) in the Union
of European Medical Specialities (UEMS), a member of the Governance Board of
the EACCME, and a new member of the UEMS school of examiners. Dr
Rubulotta is the Chair of the Committee of Medical Managers of the British
Medical Association. She is member of the editorial board of the ICU Management
and Practice Journal. She did her training in End of Life and Compassionate Care
Medicine, in the USA at Brown University, Rhode Island University Hospital in
Providence, where she received certification for the protection of study
volunteers of Rochester University. She has been working in the ethic group of the ESICM for several years
participating in international projects such as: Conflicus and Appropricus. Dr.
Rubulotta has contributed to the “Rapid
since 2007 and she is a founding member of The
International Conference of the Society for Rapid Response Systems. An avid
researcher, Dr. Rubulotta has published papers and chapters on sepsis, RRs and
the Best Paper Award by the Anna Lindh EU foundation in 2007. Dr. Rubulotta has
studied five different European languages. Dr Rubulotta has been invited as a speaker at
national and international meetings.
Interested in what SG-ANZICS 2018 has to offer? Don’t miss out!